Urabe Y, Tanaka S, Saito Y, Igarashi M, Watanabe T, Sugihara K
Endoscopy, Hiroshima University, Hiroshima.
Endoscopy, National Cancer Center Hospital, Tokyo.
Z Gastroenterol. 2015 Apr;53(4):291-301. doi: 10.1055/s-0034-1385764. Epub 2015 Apr 10.
PURPOSE: In 1977, the Japanese Society for Cancer of the Colon and Rectum (JSCCR) published the first edition of the general guidelines that described how to record clinical and histopathological findings of colorectal carcinomas (CRCs) and how to treat these cancers, and since then, the guidelines were revised several times. The aim of this study was to examine the impact of the revisions of the JSCCR guidelines on the treatment of submucosal CRCs (T1-CRCs) in Japanese clinical settings. METHODS: Questionnaires were sent to all 391 member institutions of the JSCCR. The questionnaires consisted of 2 parts: details of the institutions and treatment strategies for T1-CRCs. RESULTS: 73 (19 %) institutions responded to the survey. The number of treated T1-CRCs has increased year by year, and the rate of endoscopic resection for T1-CRCs has significantly increased with revisions of the guidelines (1417 [47 %] of 2985 T1-CRCs in 2003 - 2005, 2110 [50 %] of 4212 in 2006 - 2008, and 2546 [54 %] of 4686 in 2009 - 2011, P<.05). CONCLUSION: The revisions of the JSCCR guidelines have influenced the treatment of T1-CRCs in Japanese clinical settings. There is room to revise the criteria for curative endoscopic resection to avoid unnecessary surgeries.
目的:1977年,日本结直肠癌学会(JSCCR)出版了第一版通用指南,该指南描述了结直肠癌(CRC)临床和组织病理学检查结果的记录方法以及这些癌症的治疗方法,从那时起,该指南多次修订。本研究的目的是探讨JSCCR指南修订对日本临床环境中黏膜下CRC(T1期CRC)治疗的影响。 方法:向JSCCR的所有391个成员机构发送问卷。问卷由两部分组成:机构详情和T1期CRC的治疗策略。 结果:73家(19%)机构回复了调查。T1期CRC的治疗数量逐年增加,随着指南的修订,T1期CRC的内镜切除率显著提高(2003 - 2005年2985例T1期CRC中有1417例[47%],2006 - 2008年4212例中有2110例[50%],2009 - 2011年4686例中有2546例[54%],P<0.05)。 结论:JSCCR指南的修订对日本临床环境中T1期CRC的治疗产生了影响。有必要修订根治性内镜切除标准,以避免不必要的手术。
Gan To Kagaku Ryoho. 2010-4
Rofo. 2016-4
Clin Gastroenterol Hepatol. 2013-8-17
World J Gastrointest Endosc. 2025-6-16